A novel quality of life instrument for deep brain stimulation in movement disorders

Objective: To develop a short instrument to examine quality of life (QoL) which specifically addresses patients with movement disorders treated by deep brain stimulation (DBS). Design: The instrument was developed within an existing concept of a modular questionnaire (questions on life satisfaction: “general life satisfaction” QLSM-A, and “satisfaction with health” QLSM-G), in which each item is weighted according to its relative importance to the individual. Methods: Items were generated by interviews with 20 DBS patients, followed by item reduction and scale generation, factor analysis to determine relevant and final questionnaire items, estimation of reliability, and validation based on the medical outcome study 36 item short form health survey (SF-36) and the EuroQol (EQ-5D) (data from 152 patients with Parkinson’s disease, essential tremor, or idiopathic torsion dystonia, including 75 patients with DBS). Results: Initial questionnaires were reduced to 12 items for a “movement disorder module” (QLSM-MD), and five items for a “deep brain stimulation module” (QLSM-DBS). Psychometric analysis revealed Cronbach’s α values of of 0.87 and 0.73, and satisfactory correlation coefficients for convergent validity with SF-36 and EQ-5D. Conclusions: QLSM-MD and QLSM-DBS can evaluate quality of life aspects of DBS in movement disorders. Psychometric evaluation showed the questionnaires to be reliable, valid, and well accepted by the patients.

[1]  R. Fitzpatrick,et al.  PDQ-39: a review of the development, validation and application of a Parkinson’s disease quality of life questionnaire and its associated measures , 1998, Journal of Neurology.

[2]  Tremor assessment and quality of life measurements. , 2000, Neurology.

[3]  Steven Taylor,et al.  Exploratory factor analysis of the Pain Anxiety Symptoms Scale in patients with chronic pain complaints , 1997, Pain.

[4]  M. Åsberg,et al.  A New Depression Scale Designed to be Sensitive to Change , 1979, British Journal of Psychiatry.

[5]  M. Bullinger [Health related quality of life and subjective health. Overview of the status of research for new evaluation criteria in medicine]. , 1997, Psychotherapie, Psychosomatik, medizinische Psychologie.

[6]  A L Benabid,et al.  Deep brain stimulation of the subthalamic nucleus for Parkinson's disease: methodologic aspects and clinical criteria. , 2000, Neurology.

[7]  P. Herschbach,et al.  Questions on Life Satisfaction (FLZM) - A Short Questionnaire for Assessing Subjective Quality of Life , 2000 .

[8]  M. Jahanshahi,et al.  Perceived stigma in Spasmoic Torticollis , 2001, Movement disorders : official journal of the Movement Disorder Society.

[9]  S. Saxena,et al.  The World Health Organization Quality of Life assessment (WHOQOL): position paper from the World Health Organization. , 1995, Social science & medicine.

[10]  A. Tröster,et al.  Health-Related Quality of Life in Parkinson's Disease after Pallidotomy and Deep Brain Stimulation , 2000, Brain and Cognition.

[11]  P. Bossuyt,et al.  A comparison of continuous thalamic stimulation and thalamotomy for suppression of severe tremor. , 2000, The New England journal of medicine.

[12]  A. Tröster,et al.  Neuropsychological and quality of life outcome after thalamic stimulation for essential tremor , 1999, Neurology.

[13]  Marjan Jahanshahi,et al.  What contributes to quality of life in patients with Parkinson's disease? , 2000, Journal of neurology, neurosurgery, and psychiatry.

[14]  W. Oertel,et al.  Health-Related Quality of Life and Healthcare Utilisation in Patients with Parkinson’s Disease , 2012, PharmacoEconomics.

[15]  P. Krack,et al.  Deep-brain stimulation of the subthalamic nucleus or the pars interna of the globus pallidus in Parkinson's disease. , 2001, The New England journal of medicine.

[16]  W C Koller,et al.  Deep brain stimulation of the Vim nucleus of the thalamus for the treatment of tremor. , 2000, Neurology.

[17]  R. Brooks EuroQol: the current state of play. , 1996, Health policy.

[18]  Laurent Vercueil,et al.  Deep brain stimulation in the treatment of severe dystonia , 2001, Journal of Neurology.

[19]  C. Sherbourne,et al.  The MOS 36-Item Short-Form Health Survey (SF-36) , 1992 .

[20]  C. Strasburger,et al.  Development and psychometric properties of a disease-specific quality of life questionnaire for adult patients with growth hormone deficiency. , 2001, European journal of endocrinology.

[21]  D. Patrick,et al.  Rapid translation of quality of life measures for international clinical trials: avoiding errors in the minimalist approach , 1994, Quality of Life Research.

[22]  C. Gudex,et al.  Effect of dystonia and botulinum toxin treatment on health‐related quality of life , 1998, Movement disorders : official journal of the Movement Disorder Society.

[23]  A. Beck,et al.  An inventory for measuring depression. , 1961, Archives of general psychiatry.

[24]  C. McHorney,et al.  The MOS 36‐Item Short‐Form Health Survey (SF‐36): II. Psychometric and Clinical Tests of Validity in Measuring Physical and Mental Health Constructs , 1993, Medical care.